Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific...
Patent
1996-01-24
1997-09-02
Feisee, Lila
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
514686, 530402, 540507, 540512, 540514, A61K 4500, C07D24328
Patent
active
056629117
ABSTRACT:
Benzodiazepine protein conjugates of the formula I ##STR1## wherein R1 is hydrogen, a methyl group or R, R2 is hydrogen, a hydroxyl or an OR group, with R1 or R2 containing an R group,
R3 is a halogen, NO2 or NH2,
X is hydrogen or a halogen,
wherein R is a group of the formula II, wherein Z is a macromolecular immunogen reactive carrier substance and n is 2 or 3.
The benzodiazepine protein conjugates are used as immunogens to obtain antibodies to benzodiazepines.
The invention also relates to an immunoassay for the detection of benzodiazepines where the so generated antibodies are used.
REFERENCES:
patent: 4046636 (1977-09-01), Ullmann et al.
patent: 5434052 (1995-07-01), Khanna
Randall & Banziger, J. Med. Chem. 1965, 8 :815-812.
Current Protocols in Mol Bio, Ausubel et al., Eds (Green Pub. Ass. & Wiley-Interscience, 1992, p. 11.1.2).
Harlow & Lane, Antibodies, Cold Spring Harbor Lab, 1988, p. 72.
Huber Erasmus
Josel Hans-Peter
Klein Christian
Zink Bruno
Boehringer Mannheim GmbH
Feisee Lila
Ungar Susan
LandOfFree
Benzodiazepine protein conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzodiazepine protein conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzodiazepine protein conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-306195